Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Comment by Canadian0620144on Feb 15, 2022 2:23pm
164 Views
Post# 34430951

RE:RE:Just wondering

RE:RE:Just wondering My guess will take more than having a test that works. The next major news will be FDA approval in next few weeks. 
I think will happen soon next Friday but just a guess.  Volume last month Jan 16th-Feb 15th 10ml shares all at average 0.3745. High 0.435 Low 0.325. Nice volume today 2.1ml averaging 0.401.
Can't blame the traders who booked a +10% profit. Currently buying under 0.35 and selling over 0.40 has been a very good trade.
I'm in for the long term believe these testing tools will be necessary and in use forever. Once FDA has approved we will start to see purchase agreements this should be what starts moving the share price. Withought the contracts and forward earningsTHRM is limited to retail high risk investors and short term traders. I'm looking forward to seeing margin on testing kit prices for commercial sale and then the approved home use kits. Once ramped up to 2ml tests per month to start. Several billion people are a huge market. Anti Vax 10% are not anti test and Pro Vax 90% are clamering for quick inexpensive easy use testing.  
<< Previous
Bullboard Posts
Next >>